Physician profile
Benjamin D Webb
NPI 1487873329
$2,583.05
in general payments reported to CMS, 2019-2025
19 companies · $587 in 2025
The $587 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $213 · 2021: $155 · 2022: $393 · 2023: $496 · 2024: $452 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,535.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $694.69 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $639.19 | 2020-2025 | Dupixent |
| Genzyme Corporation | $289.99 | 2019-2025 | |
| Glaxosmithkline, LLC. | $213.45 | 2023-2025 | Nucala |
| Arrinex, INC. | $146.55 | 2019 | |
| Medtronic, INC. | $127.25 | 2023-2025 | Propel, Sinuva, Nuvent |
| Alk-Abello, INC | $112.42 | 2020-2023 | Grastek, Ragwitek, Odactra |
| Acclarent, INC | $69.15 | 2019-2023 | Trudi Nav Cable |
| Aerin Medical INC. | $56.46 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $41.29 | 2021 | |
| Stryker Corporation | $32.39 | 2019-2020 | |
| Checkpoint Surgical, INC | $29.05 | 2020 | |
| Itamar Medical INC | $23.92 | 2024 | Watchpatone |
| Neurent Medical Limited | $22.32 | 2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Paratek Pharmaceuticals, INC. | $19.96 | 2025 | Xhance |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $17.99 | 2023 | Ryaltris |
| Phathom Pharmaceuticals, INC. | $17.10 | 2025 | Voquezna |
| Smith+Nephew, INC. | $16.81 | 2024 | Tula |
| Arbor Pharmaceuticals, INC. | $13.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.